Description:
A drug that contains the active ingredient cabozantinib-s-malate and is used alone or with other drugs to treat certain types of hepatocellular carcinoma (a type of liver cancer), renal cell carcinoma (a type of kidney cancer), and differentiated thyroid cancer. It is also being studied in the treatment of other types of cancer. Cabometyx blocks certain proteins, which may help keep cancer cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. Cabometyx is a type of tyrosine kinase inhibitor and a type of angiogenesis inhibitor.
